Barclays Downgrades Xylem to Equal-Weight, Lowers Price Target to $104

Benzinga · 4d ago
Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.